These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19933018)

  • 1. Intra-operative use of PET probe for localization of FDG avid lesions.
    Molina MA; Goodwin WJ; Moffat FL; Serafini AN; Sfakianakis GN; Avisar E
    Cancer Imaging; 2009 Sep; 9(1):59-62. PubMed ID: 19933018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative (18)F-fluorodeoxyglucose-guided imaging using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy.
    Murrey DA; Bahnson EE; Hall NC; Povoski SP; Mojzisik CM; Young DC; Sharif S; Johnson MA; Abdel-Misih S; Martin EW; Knopp MV
    Am J Surg; 2009 Dec; 198(6):834-40. PubMed ID: 19969138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of FDG-probe guided surgery.
    Vos CG; Hartemink KJ; Muller S; Oosterhuis JW; Meijer S; van den Tol MP; Comans EF
    Acta Chir Belg; 2012; 112(6):414-8. PubMed ID: 23397821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery.
    Gulec SA; Daghighian F; Essner R
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9020-9027. PubMed ID: 16865592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
    Schaefer NG; Strobel K; Taverna C; Hany TF
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):60-7. PubMed ID: 17021808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorodeoxyglucose F18(FDG)-probe guided biopsy].
    Hartemink KJ; Muller S; Smulders YM; Petrousjka van den Tol M; Comans EF
    Ned Tijdschr Geneeskd; 2010; 154():A1884. PubMed ID: 20858312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routinely staging gastric cancer with
    Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
    Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
    Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
    AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative detection of ¹⁸F-FDG-avid tissue sites using the increased probe counting efficiency of the K-alpha probe design and variance-based statistical analysis with the three-sigma criteria.
    Povoski SP; Chapman GJ; Murrey DA; Lee R; Martin EW; Hall NC
    BMC Cancer; 2013 Mar; 13():98. PubMed ID: 23496877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma.
    Povoski SP; Hall NC; Martin EW; Walker MJ
    World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Evaluation of
    Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
    J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
    Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
    J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid radioguided occult lesion localization (hybrid ROLL) of (18)F-FDG-avid lesions using the hybrid tracer indocyanine green-(99m)Tc-nanocolloid.
    KleinJan GH; Brouwer OR; Mathéron HM; Rietbergen DD; Valdés Olmos RA; Wouters MW; van den Berg NS; van Leeuwen FW
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):292-7. PubMed ID: 27174865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
    Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET probe-guided surgery: applications and clinical protocol.
    Gulec SA; Hoenie E; Hostetter R; Schwartzentruber D
    World J Surg Oncol; 2007 Jun; 5():65. PubMed ID: 17555587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.